Fecal microbial transplantation (FMT) for inflammatory diseases or refractory immune checkpoint inhibitor therapy is less effective than for preventing recurrent Clostridioides difficile infection. This commentary outlines strategies to use biomarkers of successful FMT to guide newer approaches to restore microbial homeostasis in individuals with dysbiosis-mediated inflammation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.chom.2024.07.023 | DOI Listing |
Publication Analysis
Top Keywords
microbiome modification
4
modification personalized
4
personalized treatment
4
treatment dysbiotic
4
dysbiotic diseases
4
diseases fecal
4
fecal microbial
4
microbial transplantation
4
transplantation fmt
4
fmt inflammatory
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!